Fee advice - establishing a ecu evaluation framework for Risk-free and sustainable by design and styleSummary Tirzepatide is a completely new molecule capable of controlling glucose blood concentrations by combining the dual agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-one (GLP-one) receptors. GIP and GLP1